442 related articles for article (PubMed ID: 25620629)
1. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
Laska IF; Crichton ML; Shoemark A; Chalmers JD
Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
[TBL] [Abstract][Full Text] [Related]
3. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
4. Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.
Xu MJ; Dai B
Ther Adv Respir Dis; 2020; 14():1753466620936866. PubMed ID: 32615859
[TBL] [Abstract][Full Text] [Related]
5. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J
Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
[TBL] [Abstract][Full Text] [Related]
6. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Sangiovanni S; Morales EI; Fernández-Trujillo L
Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314
[TBL] [Abstract][Full Text] [Related]
7. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review.
Brodt AM; Stovold E; Zhang L
Eur Respir J; 2014 Aug; 44(2):382-93. PubMed ID: 24925920
[TBL] [Abstract][Full Text] [Related]
8. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
[TBL] [Abstract][Full Text] [Related]
9. Inhaled antibiotics in non-cystic fibrosis bronchiectasis: A meta-analysis.
Xu L; Zhang F; Du S; Yu Q; Chen L; Long LH; Li YM; Jia AH
Pharmazie; 2016 Sep; 71(9):491-498. PubMed ID: 29441843
[TBL] [Abstract][Full Text] [Related]
10. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
[TBL] [Abstract][Full Text] [Related]
12. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
[TBL] [Abstract][Full Text] [Related]
13. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
Martínez García MÁ; Soler Cataluña JJ; Serra PC
Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of efficacy and safety of inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis patients.
Wang S; Zhang A; Yao X
Intern Med J; 2021 Sep; 51(9):1505-1512. PubMed ID: 33469994
[TBL] [Abstract][Full Text] [Related]
15. Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Tejada S; Campogiani L; Solé-Lleonart C; Gómez A; Gallego M; Vendrell M; Soriano JB; Rello J
Eur J Intern Med; 2021 Aug; 90():77-88. PubMed ID: 33947626
[TBL] [Abstract][Full Text] [Related]
16. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.
Serisier DJ; Bilton D; De Soyza A; Thompson PJ; Kolbe J; Greville HW; Cipolla D; Bruinenberg P; Gonda I;
Thorax; 2013 Sep; 68(9):812-7. PubMed ID: 23681906
[TBL] [Abstract][Full Text] [Related]
17. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
Rubin BK
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME
Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427
[TBL] [Abstract][Full Text] [Related]
20. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
